XML 45 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities    
Net income (loss) $ 2,166 $ (47,667)
Depreciation and amortization 13,405 19,937
Recovery of receivables from foundry supplier 0 (439)
Write-off of equipment deposit (2,242) (3,735)
Write-off of equipment deposit 1,730 0
Realized gain on sales of marketable securities (385) 0
Accretion of interest on long-term debt 321 260
Share-based compensation expense 15,617 14,762
Excess tax benefit on share-based compensation (572) (650)
Non-cash acquisition-related and other charges, net 323 238
Changes in operating assets and liabilities, net of acquisitions    
Accounts receivable 11,858 (7,837)
Inventories 27,814 13,528
Current and other assets 16,720 (31,162)
Trade accounts payable (1,171) (30,608)
Accrued and other liabilities (32,465) 36,444
Income taxes payable (3,054) 8,909
Deferred income on shipments to distributors (3,828) 16,067
Net cash provided by (used in) operating activities 46,237 (11,953)
Cash flows from investing activities    
Acquisitions of fixed assets (17,025) (4,099)
Proceeds from the sale of business 0 5,092
Sales of marketable securities 3,071 0
Acquisition of businesses, net of cash acquired 0 (25,852)
Acquisitions of intangible assets (784) (1,000)
Net cash used in investing activities (14,738) (25,859)
Cash flows from financing activities    
Repurchases of common stock (54,946) (15,436)
Proceeds from issuance of common stock 6,711 6,917
Tax payments related to shares withheld for vested restricted stock units (4,889) (3,744)
Excess tax benefit on share-based compensation 572 650
Net cash used in financing activities (52,552) (11,613)
Effect of exchange rate changes on cash and cash equivalents (351) (1,224)
Net decrease in cash and cash equivalents (21,404) (50,649)
Cash and cash equivalents at beginning of the period 276,881 293,370
Cash and cash equivalents at end of the period $ 255,477 $ 242,721